In conclusion, EZH2 promotes ovarian cancer migration and invasion via the epigenetic silencing of TIMP2 by H3K27me3 and DNA hypermethylation, which leads to the activation of MMP2 and MMP9. The gene discussed is EZH2; the disease is ovarian cancer.